Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Dendritic Nanotechnologies gets US contract for ovarian cancer diagnostic and drug delivery:

This article was originally published in Clinica

Executive Summary

Dendritic Nanotechnologies (DNT) has teamed with the US National Cancer Institute (NCI) to develop diagnostic and therapeutic delivery systems for ovarian cancer using its dendrimer nanostructures know-how. The partners have entered into an $850,000 small business innovation research contract, whereby DNT's Priostar dendrimer delivery system will be combined with a magnetic resonance imaging agent to create an improved product for detecting and monitoring cancerous tissue. A second product will combine the Priostar dendrimer with approved cancer-fighting drugs to improve and deliver therapy for ovarian epithelial cancer. Mount Pleasant, Michigan-based DNT expects the project to result in the filing of investigational new drug (IND) applications for the diagnostic imaging technology and for the therapeutic technology. Dendrimers are a type of precisely-defined, branched nanostructure.

You may also be interested in...



Basilea Stresses Derazantinib's FGFR Kinase Differentiation

Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.

 

ATMPs Put EU Cross-Border Healthcare On The Map

Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.

Start-Up Snapshot: Nanomedic’s Electro-Spinning, Portable Wound Care Device

At the OurCrowd Global Investor Summit in Jerusalem, Israel, on 13 February, Medtech Insight met wound care device company Nanomedic to find out more about its unique electro-spinning technology.

Topics

UsernamePublicRestriction

Register

MT053211

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel